Related Experiment Video
Updated: Jun 4, 2025

10:28
A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks
Published on: June 26, 2020
9.6K
Alkhumra Hemorrhagic Fever Virus (AHFV): A Concise Overview
Amrita Srivastava1, Shakuntala Mahilkar2, Chandrama Prakash Upadhyaya1
1Department of Biotechnology, Dr. Harisingh Gour Vishwavidyalaya (A Central University), Madhya Pradesh, India.
The Yale Journal of Biology and Medicine
|December 20, 2024
Summary
Alkhumra hemorrhagic fever virus (AHFV) causes Alkhumra fever, transmitted by ticks. This review explores AHFV molecular biology, pathogenesis, and potential therapeutic targets for this flavivirus.
Area of Science:
- Virology
- Molecular Biology
- Infectious Diseases
Background:
- Alkhumra fever is a viral disease caused by Alkhumra hemorrhagic fever virus (AHFV), a flavivirus.
- AHFV is transmitted to humans via infected ticks, primarily identified in Saudi Arabia in 1995.
- The virus can cause symptoms ranging from mild flu-like illness to severe hemorrhagic fever.
Purpose of the Study:
- To provide an insightful understanding of the molecular biology of AHFV.
- To elucidate the pathogenesis of Alkhumra hemorrhagic fever.
- To identify potential therapeutic targets for AHFV infections.
Main Methods:
- Review of existing literature on AHFV.
- Analysis of AHFV genome structure and protein processing.
- Examination of viral replication and host interaction mechanisms.
Main Results:
- The AHFV genome is a ~10.2 kb positive-sense single-stranded RNA.
- Viral and host proteases process the ORF-encoded polyprotein into structural and non-structural proteins.
- Understanding these molecular processes is key to understanding pathogenesis.
Conclusions:
- Further research into AHFV molecular biology and pathogenesis is crucial.
- Identifying specific viral proteins and pathways can lead to targeted therapeutic strategies.
- Effective control of Alkhumra fever requires a comprehensive understanding of the virus.
Related Concept Videos
Introduction to Hemostasis
5.5K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
5.5K
Methods of reducing fever
642
The signs and symptoms of fever include hot and dry skin, flushed face, thirst, muscle aches, anorexia, headache, tachycardia, tachypnea, and fatigue. Elevated body temperature is reduced using two methods: pharmacological and nonpharmacological. Proper identification and treatment of the root cause of a fever is of utmost importance.
Pharmacological Methods of Reducing Fever:
Pharmacological Methods of Reducing Fever:
642
Rh Blood Group
1.3K
The Rhesus (Rh) antigen is crucial in determining blood groups and ensuring compatibility during blood transfusions.
1.3K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
608
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
608

